Systemic inflammation, metabolic syndrome and progressive renal disease - PubMed (original) (raw)

Review

Systemic inflammation, metabolic syndrome and progressive renal disease

Pietro Cirillo et al. Nephrol Dial Transplant. 2009 May.

No abstract available

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Potential role of inflammatory molecules in fructose/uric acid-related events.

Comment in

References

    1. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29:439–443. - PubMed
    1. Albert CM, Ma J, Rifai N, et al. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation. 2002;105:2595–2599. - PubMed
    1. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843. - PubMed
    1. Soriano S, González L, Martín-Malo A, et al. C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3–5 patients. Clin Nephrol. 2007;67:352–357. - PubMed
    1. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: is C-reactive protein the missing link? Kidney Int. 2001;59:407–414. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources